# Advanced Oncotherapy Plc Non-dilutive financing plan update

- Link: https://www.directorstalkinterviews.com/advanced-oncotherapy-plc-non-dilutive-financing-plan-update/412721943
- Published: 2017-01-23T07:05:54+00:00
- Author: Giles Arbor

**Advanced Oncotherapy Plc** (LON:AVO), the developer of next-generation proton 
therapy systems for cancer treatment, announced today that, in September 2016, it
commenced discussions concerning a proposal it had received from a potential strategic
partner that involves, inter alia, non-dilutive financing arrangements, which were
mentioned in the announcement of 30 September 2016. Discussions with this potential
partner are continuing and their scope has been expanded. The Company will keep 
the market informed of any developments accordingly.

Advanced Oncotherapy Plc is a provider of particle therapy with protons that harnesses
the best in modern technology. AVO’s team “ADAM”, based in Geneva, focuses on the
development of a proprietary proton accelerator called Linac Image Guided Hadron
Technology (LIGHT). LIGHT accelerates protons to the energy levels achieved in legacy
machines but in a unit that is a quarter of the size and between a quarter and a
fifth of the cost. This compact configuration delivers proton beams in a way that
facilitates greater precision and electronic control which is not achievable with
older technologies.

Share on:
